Immuno-Oncology Equity Research Associate — Deep Dive

Leerink Partners; New York (NY); On-site; USD 135,000 - 170,000; Full time

Job summary

Leerink Partners in New York is seeking an Equity Research Associate focused on Immuno-Oncology to support senior analysts in clinical, scientific, and financial evaluation of cancer therapies. You will develop subject‑matter expertise in trial methodology, mechanism of action, and market dynamics, while building robust financial models and contributing to research reports.

The role emphasizes primary data analysis, Monte Carlo simulations, and in‑depth valuation work, with opportunities to

Qualifications

• PhD, MD, or Master’s in a relevant scientific or quantitative field.
• Strong quantitative and analytical skills with experience in data analysis.
• Experience with statistical or simulation-based analyses (e.g., Monte Carlo).
• Experience in financial modeling and forecasting is required.

Responsibilities

• Collect and analyze primary data on cancer immunotherapy and related trials.
• Maintain a database of ongoing trials and run revenue simulations.
• Build, update, and maintain financial models.
• Formulate investment recommendations based on fundamental analysis.
• Write research reports on immunotherapy mechanisms and cancer settings.
• Stay current on company, market, scientific and regulatory developments.
• Support senior professionals at conferences and post‑conference analysis.
• Respond to inquiries from firm personnel and clients.

Skills

Quantitative analysis

Financial modeling

Excel proficiency

Written & verbal communication

Data handling

Education

PhD/MD or related Master’s

Tools

Excel

Access

Job description

Leerink Partners in New York is seeking an Equity Research Associate focused on Immuno-Oncology to support senior analysts in clinical, scientific, and financial evaluation of cancer therapies. You will develop subject‑matter expertise in trial methodology, mechanism of action, and market dynamics, while building robust financial models and contributing to research reports.

The role emphasizes primary data analysis, Monte Carlo simulations, and in‑depth valuation work, with opportunities to